Empowering the Immune System

July 6th 2025, 6:00pm

By Darlene Dobkowski, MA

TIL therapy is on the rise in melanoma, with potential for other tumor types.

Growing from Embarrassment to Admiration of My Mother’s Breast Cancer

July 6th 2025, 2:00pm

By Robyn Quesada

Funding for Cancer Research: Hope in a State of Fear

July 5th 2025, 6:00pm

By Dr. Joshua K. Sabari

Cancer is nonpartisan. It touches everyone — cutting across religion, race, ethnicity, sexual orientation and socioeconomic status.

Healing Through Advocacy and Self-Discovery After AML Diagnosis

July 5th 2025, 2:00pm

By Zachary Mirecki

Zac Mirecki reflects on six years of survivorship, sharing how his AML journey taught him to priori-tize self-care, seek connection, and support others through advocacy.

Broken Yet Unbreakable: My Previvor Journey and the Power of Symbolism

July 4th 2025, 7:00pm

By Holly Sabo

Learning I carried the BRCA1 mutation was terrifying, but it gave me the power to choose prevention, embrace survivorship, and honor my journey with purpose.

My Imaginary Fear of Cancer Recurrence

July 4th 2025, 1:00pm

By Bonnie Annis

Fear is a powerful enemy of the mind but there’s another word that has the same power. That word is a six letter one, cancer.

How Multidisciplinary Care Impacts Prostate Cancer Treatment

July 3rd 2025, 7:00pm

By Ryan Scott

Multidisciplinary care, a collaborative approach where various healthcare disciplines come together, is essential for treating those with prostate cancer.

A New Frontier in Melanoma Treatment

July 3rd 2025, 5:00pm

By Mike Hennessy Jr.

A significant development in the treatment of advanced melanoma has recently emerged: tumor-infiltrating lymphocyte (TIL) therapy.

Reflections After Nine Years as a Bladder Cancer Survivor

July 3rd 2025, 1:00pm

By Chester Freeman

Nine years after my bladder cancer diagnosis, I reflect on its recurrence, caregiving, grief, and my new life with leukemia and renewed gratitude.

Zegfrovy FDA Approved for EGFR Exon 20 Non-Small Cell Lung Cancer

July 2nd 2025, 9:11pm

By Spencer Feldman

The FDA approved Zegfrovy for advanced non-small cell lung cancer with EGFR exon 20 mutations after chemotherapy.

This Wasn’t the Plan: My Mother and Her Silence

July 2nd 2025, 9:00pm

By Ajay Shanker Mishra

In part 4, the author reflects on her mother’s silent strength and unwavering love during her cancer journey, as she cared for her daughter while silently battling her own illness.

Veteran Credits CAR T-Cell Therapy With Helping Him Reach Remission

July 2nd 2025, 7:00pm

By Spencer Feldman

Mark Daniels, 83, says CAR T-cell therapy and strong support helped him overcome lymphoma twice and return to the fitness-focused life he values.

Tipping My Hat to the Heroes of the Cancer Community

July 2nd 2025, 6:00pm

By Tamron Little

Tamron Little was diagnosed with peritoneal mesothelioma in 2007 as a 21-year-old new mother. Catch up on Tamron's blogs here!

FDA Grants Accelerated Approval to Lynozyfic for Multiple Myeloma

July 2nd 2025, 4:32pm

By Spencer Feldman

The FDA approved Lynozyfic for relapsed multiple myeloma, but serious risks require restricted use under a special safety program.

Living After Cancer: A Cancer Thriver Shares Her Story

July 2nd 2025, 4:00pm

By Ryan Scott

Valarie Traynham, a cancer thriver and patient advocate, imparts advice and discusses survivorship after a cancer diagnosis.